logo

Carlos Arteaga, MD

Carlos Arteaga, MD

Oncology Nashville, TN

Professor of Medicine, Vanderbilt University

Office Address

Office Map
  • 2220 Pierce Ave
    777 Prb
    Nashville, TN 37232
    Phone: (615) 936-3524
    Fax: (615) 343-7602

Dr. Arteaga's Clinical Specialties & Interests

  • Oncology: General Oncology

Dr. Arteaga's Education & Medical Training

  • University of Texas Health Science Center at San AntonioUniversity of Texas Health Science Center at San AntonioFellowship, Hematology
  • Emory UniversityEmory UniversityResidency, Internal Medicine
  • Universidad de Guayaquil FOMUniversidad de Guayaquil Faculty of MedicineMedical School

Dr. Arteaga's Certifications & Licensure

  • TN State Medical LicenseTN State Medical License1989 - 2014
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineMedical Oncology

Dr. Arteaga's Awards, Honors, & Recognition

  • The American Society for Clinical InvestigationElected MemberThe American Society for Clinical Investigation, 1999
  • Marquis Whos WhoWhos Who in Medicine and HealthcareMarquis Whos Who

Dr. Arteaga's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Vanderbilt Training Program In Academic Cancer Research
    Vanderbilt Training Program In Academic Cancer ResearchNational Cancer Institute
    2010 - 2011
  • Administrative And Outreach Core
    Administrative And Outreach CoreNational Cancer Institute
    2008 - 2011
  • Career Development Program
    Career Development ProgramNational Cancer Institute
    2008 - 2011
  • Resistance To Antiestrogen Therapy In Hormone Receptor-Positive Breast Cancer
    Resistance To Antiestrogen Therapy In Hormone Receptor-Positive Breast CancerNational Cancer Institute
    2008 - 2011
  • Developmental Research Program
    Developmental Research ProgramNational Cancer Institute
    2008 - 2011
  • Her(Erbb) Inhibitors In Untreated Operable Breast Cancer
    Her(Erbb) Inhibitors In Untreated Operable Breast CancerNational Cancer Institute
    2004 - 2004
  • Spore In Breast Cancer
    Spore In Breast CancerNational Cancer Institute
    2003 - 2011
  • Training Program In Breast Cancer Research
    Training Program In Breast Cancer ResearchNational Cancer Institute
    2001 - 2007
  • ERBB2 Targeted Antitumor Strategies In Breast Cancer
    ERBB2 Targeted Antitumor Strategies In Breast CancerNational Cancer Institute
    1999 - 2012
  • Tgf-Betas And Receptors And Human Breast Cells
    Tgf-Betas And Receptors And Human Breast CellsNational Cancer Institute
    1999 - 2009
  • Phase I Study Antisense FOS Vector In Breast Cancer
    Phase I Study Antisense FOS Vector In Breast CancerNational Cancer Institute
    1996 - 1997
  • Role Of Tgfb-Isoforms In Human Breast Epithelial Cells
    Role Of Tgfb-Isoforms In Human Breast Epithelial CellsNational Cancer Institute
    1995 - 1998

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Tennessee Network 5
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Coventry Carelink Health Plans PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Humana/ChoiceCare+ Network PPO
  • Multiplan PHCS PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Carlos Arteaga, Dr. Carlos Arteaga, MD, Dr. C Arteaga, Dr. Carlos L. Arteaga

20 Colleague Invites!
Is this you? If so, register to see 20 messages.

Physicians, view Dr. Arteaga's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV